Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro

The European Journal of Neuroscience
D N AlfarezHarm Krugers

Abstract

Rises in corticosteroid levels, e.g. after acute stress, impair synaptic plasticity in the rat hippocampus when compared with the situation where levels are basal, i.e. under rest. We here addressed the question whether basal and raised levels of corticosterone affect synaptic plasticity similarly in animals that experienced chronic stress prior to corticosterone application. To this end, rats were exposed to a 21-day variable stress paradigm. Synaptic plasticity was examined in vitro in the dentate gyrus and CA1 hippocampal region, 24 h after exposure to the last stressor, i.e. when corticosterone levels are basal (low). First we observed that long-term potentiation was greatly impaired in both CA1 and dentate gyrus after 3 weeks of exposure to variable stress, when recorded under conditions where plasma corticosterone levels are low. Second, administration of 100 nm corticosterone in vitro reduced synaptic plasticity in CA1 of control rats, but induced no further impairment of synaptic plasticity in chronically stressed rats. Third, in the dentate gyrus, corticosterone incubation did not affect synaptic plasticity in slices from both control and stressed animals. We conclude that: (i) exposure to chronic variable stress per s...Continue Reading

References

Jan 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·J A van EekelenE R de Kloet
Jul 1, 1987·Behavioral and Neural Biology·M R FoyR F Thompson
Jan 7, 1993·Nature·T V Bliss, G L Collingridge
Apr 1, 1996·Trends in Neurosciences·W C Abraham, M F Bear
Jan 1, 1996·Physiology & Behavior·V LuineB S McEwen
Sep 23, 1997·Annals of Biomedical Engineering·J D BronzinoP J Morgane
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·L XuM J Rowan
Apr 15, 1999·Annual Review of Neuroscience·B S McEwen
Sep 11, 1999·Trends in Neurosciences·E R de KloetM Joëls
Jan 20, 2000·Journal of Neurobiology·S WangJ M Wojtowicz
Sep 14, 2000·Hippocampus·J J ChrobakG Buzsáki
Nov 24, 2001·Behavioural Brain Research·S J Lupien, M Lepage
May 10, 2002·Hippocampus·Constantine PavlidesBruce S McEwen
Aug 27, 2002·Nature Neuroscience·Bo LiLynn A Raymond
Jan 11, 2003·Journal of Neurophysiology·Henk Karst, Marian Joëls

❮ Previous
Next ❯

Citations

Jun 7, 2008·Neuromolecular Medicine·Brian R ChristieAndrea K Titterness
Nov 28, 2009·Neuromolecular Medicine·Sarah M Rothman, Mark P Mattson
Apr 16, 2004·Behavioural Brain Research·H ZhaoK L Drew
Jan 19, 2011·Molecular Psychiatry·G A van WingenG Fernández
Nov 20, 2004·Nature Reviews. Neuroscience·Carmen Sandi
May 14, 2005·Nature Reviews. Neuroscience·E Ron de KloetFlorian Holsboer
Jan 18, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Henk Karst, Marian Joëls
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Yuncai ChenTallie Z Baram
Feb 9, 2012·Molecular & Cellular Proteomics : MCP·Kim HenningsenOve Wiborg
Jun 29, 2012·Epilepsia·Jolien S van CampenKees P J Braun
Mar 14, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yuncai ChenTallie Z Baram
Oct 14, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kristen L BrunsonTallie Z Baram
Feb 5, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Theodore C DumasRobert M Sapolsky
Oct 19, 2010·International Journal of Alzheimer's Disease·L ChouliarasB P F Rutten
May 16, 2007·Neural Plasticity·Marian Joëls, Harm J Krugers
Dec 24, 2013·Frontiers in Neuroendocrinology·Brent MyersJames P Herman
Jan 5, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Xiaohan XuGuoqing Tian
Oct 4, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Angy J KallarackalScott M Thompson
Jan 25, 2016·Sleep Medicine Reviews·Elias WolfChristoph Nissen
Aug 15, 2015·Annual Review of Physiology·Terje Lømo
Oct 16, 2015·Stress : the International Journal on the Biology of Stress·Mei YuTao Zhang
May 28, 2013·Biological Psychiatry·Pedro AlvarezJon D Levine
Jan 12, 2011·Journal of Psychiatric Research·Heather C AbercrombieJerry Halverson
Jul 6, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Fu Lye WoonDawson W Hedges
Apr 13, 2010·Psychoneuroendocrinology·Marian Joëls
Apr 9, 2011·Journal of Neurodevelopmental Disorders·Elliott A Beaton, Tony J Simon
Jul 4, 2009·Behavioural Brain Research·Fabíola C R ZucchiGerlinde A Metz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.